1933 Industries Inc.
VANCOUVER, BC / ACCESSWIRE / July 16, 2021 / 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis consumer packaged goods company, announces an extraordinary meeting of holders of 10% Senior Unsecured Convertible Debentures Due September 14, 2021 (“Debentureholders”).
The meeting details are as follows:
Date: August 6, 2021
Time: 10:00 a.m. (Pacific Time)
Place: Virtual Meeting Only
A Management Information Circular (“Circular”) containing a detailed description of certain amendments for consideration (“Debenture Amendments”) has been mailed to the Company's Debentureholders of record. Due to Covid-19 restrictions, the meeting is scheduled to be held virtually and the Company encourages Debentureholders to vote by proxy, in accordance to the instructions provided in the Circular. The Circular has been filed under the Company's profile on SEDAR and is available at www.sedar.com and is also posted on the Company's website at www.1933industries.com/investors/eom-materials
Debentureholders are being asked to consider an extraordinary resolution to amend the Debentures to delist the Debentures from the Canadian Securities Exchange (the “Delisting”) in order to facilitate the implementation of the previously approved extension of the maturity date for the Debentures from September 14, 2021 to September 14, 2022 (the “Maturity Extension”).
At the meeting of Debentureholders held on April 14, 2021, the Debentureholders approved the extension of the maturity date of the Debentures from September 14, 2021 to September 14, 2022 as well as the form of the Supplemental Indenture necessary to give effect to same. As the Debentures are currently listed, in order for the CSE to approve the Maturity Extension and allow for the implementation of same, the Company must delist the Debentures. A delisting of the Debentures from the CSE requires an extraordinary approval of the Debentureholders. If the Delisting is not approved, the Maturity Extension cannot be completed.
The Board unanimously recommends that the Debentureholders vote in favour of the Debenture Amendment.
About 1933 Industries Inc.
1933 Industries is a Nevada-based, growth-orientated company, focusing on the cultivation and manufacturing of cannabis consumer branded goods in a wide range of product formats. Operating through two subsidiaries, the Company controls all aspects of the value chain with cultivation, extraction, processing, distribution and manufacturing assets supporting its diversified portfolio of cannabis brands and licensing partners. The Company owns 91% of Alternative Medicine Association, LC (AMA), and 100% of Infused MFG LLC.
About Alternative Medicine Association
AMA is a licensed medical and adult-use cannabis cultivation and extraction subsidiary that produces its own branded line of unique cannabis products and manufactures third-party brands. AMA's extensive menu of cannabis products include: craft cannabis flower, pre-rolls, full spectrum oils, high quality distillates, proprietary blends of terpenes, vaporizer products and boutique concentrates such as shatter, crumble, batter, sugar wax, diamonds, and live resin. AMA recently announced the launch of its ultra-craft brand Level X, an exclusive collection of exotic strains, selected specifically for their distinctive terpene profiles, high THC levels, and flavonoids With state-of-the-art cultivation and extraction facilities based in Las Vegas, Nevada, AMA seeks to offer medical patients and recreational users alike a cannabis experience that's exceptional, potent, and consistent in quality. www.amanev.com
AMA is also licensed in Nevada as an adult-use cannabis distributor.
About Canna Hemp™
With an extensive product line that includes topicals, creams, vapes, elixirs, capsules, lip balms and pre and post workout recovery sports products, 1933 Industries' proprietary Canna Hemp™ brand utilizes the power of CBD to bring natural wellness. The Company's flagship products, the Canna Hemp™ Relief Cream and Canna Hemp X™ Recovery Cream are recognized as best topicals in the market. Canna Hemp X™ is a CBD sports recovery cream for athletes, bridging the gap between recovery and top performance. All products are triple and third-party tested for safety with test results embedded via QR codes for traceability. www.cannahemp.com
For further information please contact:
Alexia Helgason, VP, IR and Corporate Communications
604-674-4756 (ext. 1)
alexia@1933industries.com
Paul Rosen, CEO
604-674-4756 (ext. 1)
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words 'anticipate', 'continue', 'estimate', 'expect', 'may', 'will', 'project', 'should', 'believe' and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE: 1933 Industries Inc.
View source version on accesswire.com:
https://www.accesswire.com/655902/1933-Industries-Announces-Extraordinary-Meeting-of-Debentureholders-to-Delist-Convertible-Debentures-in-order-to-Extend-the-Maturity-Date
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
GoodData Launches GoodData AI: Embed, Extend, and Scale Analytics with AI27.5.2025 08:30:00 CEST | Press release
AI-Native Analytics Platform That Understands Your Business - and Your Developers SAN FRANCISCO, CA / ACCESS Newswire / May 27, 2025 / GoodData today announced the general availability of GoodData AI, a next-generation analytics platform that places AI at every layer of the data stack - from raw-data ingestion to governed insight delivery - without compromising trust or compliance. Why GoodData AI Stands Apart GoodData AI is designed for enterprises that require trust, scalability, and extensibility. Its architecture is built around these foundational principles: Composable by design: Embedded, white-labeled, and API-first; built for developers to connect with any AI stack. Semantic layer and ontology: The only AI analytics engine that natively understands your business logic, ensuring every answer is both consistent and metric-perfect. Model Context Protocol (MCP) Support: Enables real-time, cross-system context that makes AI relevant. GoodData's new MCP Server Beta program is now ava
Affordable Mini LED with Premium Design - Meet the TCL C7K Series23.5.2025 04:40:00 CEST | Press release
LONDON, UNITED KINGDOM / ACCESS Newswire / May 23, 2025 / TCL, a global leader in consumer electronics and the world's No.1 Ultra-large, Mini LED, and Google TV brand, has introduced the C7K Series, a new series of 4K 144Hz QD-Mini LED TVs available in screen sizes ranging from 50" inches to 115" inches. The C7K delivers advanced backlight control, high brightness performance and immersive audio technology at pricing that challenges conventional premium categories. The C7K Series is designed for those who demand more from their screen-whether that's sharper gaming, immersive movie nights, or simply an ultra-vivid sports match. Featuring QD-Mini LED technology and TCL's Precise Dimming Series, the C7K boasts up to 2880 dimming zones on the 115" model, offering deeper blacks, contrast and colour gamut levels comparable to OLED , while also providing higher peak brightness and a longer lifespan. HDR Premium 3000 and 144Hz Motion Clarity Visual performance is driven by HDR Premium 3000, ca
TCL Brings Premium Mini LED TV to More Homes with Amazon Brand Week Savings23.5.2025 04:40:00 CEST | Press release
LONDON, UNITED KINGDOM / ACCESS Newswire / May 23, 2025 / This Amazon Brand Week (26 th May - 1 st June), TCL invites consumers to upgrade their home entertainment with exclusive offers on its latest Mini LED TV series, the 2025 Q6C-UK series. Whether you're planning a summer of sports, immersive movie nights, or epic gaming sessions, these limited-time deals make premium TV technology more accessible than ever. With cutting-edge features and limited promotional pricing, there's never been a better time to bring a cinematic experience into your living room.t. At the heart of the 2025 Q-Series is TCL's next-generation QD-Mini LED technology , combining the best of QLED and OLED for pixel-level lighting precision. The advanced Quantum Dot Pro and Mini LED backlight system deliver stunning contrast, ultra-high peak brightness , and a wider colour gamut - bringing vivid colours and striking realism to every scene. With up to 512 dimming zones (on the 98" Q6C-UK model), viewers enjoy deeper
BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent23.5.2025 03:05:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / May 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that the examining division of the European Patent Office ("EPO") has provided formal notice of the EPO‘s intention to grant BioNxt its core patent without significant changes. The Company's core patent filing was a comprehensive application for the sublingual delivery of anticancer drugs for the treatment of autoimmune neurodegenerative diseases. This patent family provides numerous proprietary product development and commercialization opportunities, including BioNxt's lead product, BNT23001, a sublingual thin-film formulation of Cladribine for the treatment of multiple sclerosis (MS). "Confirmation of the Company's flagship intellectual property asset in Europe is a major milestone for BioNxt," stated Hugh Rogers, CEO of BioNxt. "We expect the European paten
DCLI Drives Fleet Efficiencies with BlackBerry Radar Deployment Across 100,000 Chassis22.5.2025 07:56:00 CEST | Press release
Innovative Asset Monitoring Technology Selected by U.S.'s Largest Container Chassis Provider WATERLOO, ON / ACCESS Newswire / May 22, 2025 / BlackBerry Limited (NYSE:BB)(TSX:BB) today announced that Direct ChassisLink, Inc. ("DCLI"), the largest provider of container chassis to the U.S. intermodal industry, will deploy BlackBerry® Radar® across 100,000 of its DCL53 domestic 53-foot chassis. The rollout is part of a major initiative DCLI is undertaking to enhance the quality, reliability, visibility and operational efficiency of its fleet, with a view to setting a new freight industry standard for data driven decision-making. The deployment represents a deepening in the companies' technological collaboration. DCLI has utilized Radar devices on a subset of its fleet for over five years and after seeing the reliability and intelligence they provide, decided to exponentially increase the number of its chassis deployed with the solution while also recognizing Radar as a top tier supplier. W
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom